Treosulfan
(Redirected from Trecondi)
Treosulfan is a chemotherapy agent used primarily in the treatment of ovarian cancer. It is an alkylating agent that works by interfering with the DNA replication process in cancer cells, leading to cell death. Treosulfan is also being investigated for its potential use in hematopoietic stem cell transplantation (HSCT).
Mechanism of Action[edit | edit source]
Treosulfan is a prodrug that is converted in the body to a bifunctional alkylating agent. It forms cross-links in DNA, which prevents the cancer cells from dividing and leads to apoptosis. This mechanism is similar to other alkylating agents like cyclophosphamide and melphalan.
Clinical Uses[edit | edit source]
Treosulfan is primarily used in the treatment of ovarian cancer, particularly in patients who have not responded to other treatments. It is also being studied for use in hematopoietic stem cell transplantation as a conditioning agent. This involves preparing the patient's body to receive new stem cells by eliminating existing bone marrow cells.
Administration and Dosage[edit | edit source]
Treosulfan is usually administered intravenously. The dosage and schedule depend on the type and stage of cancer being treated, as well as the patient's overall health and response to the medication. It is often given in combination with other chemotherapy drugs.
Side Effects[edit | edit source]
Common side effects of treosulfan include:
- Nausea
- Vomiting
- Myelosuppression (decreased production of blood cells)
- Alopecia (hair loss)
- Fatigue
More severe side effects can include:
- Infections due to low white blood cell counts
- Bleeding due to low platelet counts
- Anemia due to low red blood cell counts
Research and Development[edit | edit source]
Treosulfan is currently being studied in various clinical trials to evaluate its efficacy and safety in different types of cancer and in hematopoietic stem cell transplantation. Researchers are also investigating its potential use in combination with other chemotherapy agents and targeted therapies.
See Also[edit | edit source]
- Ovarian cancer
- Chemotherapy
- Alkylating agent
- Hematopoietic stem cell transplantation
- Cyclophosphamide
- Melphalan
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD